List of Tables

Table 1. Broluzumab Biosimilars Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Broluzumab Biosimilars Market Restraints

Table 3. Broluzumab Biosimilars Market Trends

Table 4. Broluzumab Biosimilars Industry Policy

Table 5. Global Broluzumab Biosimilars Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Broluzumab Biosimilars Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Broluzumab Biosimilars Sales Quantity by Company, (2020-2025) & (Units), Ranked Based on Sales in 2024

Table 8. Global Broluzumab Biosimilars Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Broluzumab Biosimilars Average Selling Price (ASP) by Company, (2020-2025) & (K USD/Unit)

Table 10. Global Broluzumab Biosimilars Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Broluzumab Biosimilars Mergers & Acquisitions, Expansion Plans

Table 12. Global Broluzumab Biosimilars Manufacturers Product Type

Table 13. Head Office and Broluzumab Biosimilars Production Site of Key Manufacturer

Table 14. Broluzumab Biosimilars Capacity of Major Manufacturers and Future Plan

Table 15. China Broluzumab Biosimilars Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Broluzumab Biosimilars Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Broluzumab Biosimilars Sales Quantity by Company, (2020-2025) & (Units), Ranked Based on Sales in 2024

Table 18. China Broluzumab Biosimilars Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Broluzumab Biosimilars Production & Forecast by Region, 2020 VS 2024 VS 2031, (Units)

Table 20. Global Broluzumab Biosimilars Production by Region, 2020-2025, (Units)

Table 21. Global Broluzumab Biosimilars Production Forecast by Region, 2026-2031, (Units)

Table 22. Global Key Players of Broluzumab Biosimilars Upstream (Raw Materials)

Table 23. Global Broluzumab Biosimilars Typical Customers

Table 24. Broluzumab Biosimilars Typical Distributors

Table 25. by Type, Global Broluzumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Broluzumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Broluzumab Biosimilars Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Broluzumab Biosimilars Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Table 30. By Country, Global Broluzumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Broluzumab Biosimilars Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Broluzumab Biosimilars Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Table 34. By Country, Global Broluzumab Biosimilars Sales Quantity Market Share, 2020-2031

Table 35. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 36. Novartis Broluzumab Biosimilars Models, Specifications, and Application

Table 37. Novartis Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 38. Novartis Company Profile and Main Business

Table 39. Novartis Recent Developments

Table 40. Genentech Company Information, Head Office, Market Area, and Industry Position

Table 41. Genentech Broluzumab Biosimilars Models, Specifications, and Application

Table 42. Genentech Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 43. Genentech Company Profile and Main Business

Table 44. Genentech Recent Developments

Table 45. Roche Company Information, Head Office, Market Area, and Industry Position

Table 46. Roche Broluzumab Biosimilars Models, Specifications, and Application

Table 47. Roche Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 48. Roche Company Profile and Main Business

Table 49. Roche Recent Developments

Table 50. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 51. Pfizer Broluzumab Biosimilars Models, Specifications, and Application

Table 52. Pfizer Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 53. Pfizer Company Profile and Main Business

Table 54. Pfizer Recent Developments

Table 55. Sartorius Company Information, Head Office, Market Area, and Industry Position

Table 56. Sartorius Broluzumab Biosimilars Models, Specifications, and Application

Table 57. Sartorius Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 58. Sartorius Company Profile and Main Business

Table 59. Sartorius Recent Developments

Table 60. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 61. Eli Lilly Broluzumab Biosimilars Models, Specifications, and Application

Table 62. Eli Lilly Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 63. Eli Lilly Company Profile and Main Business

Table 64. Eli Lilly Recent Developments

Table 65. Bayer Company Information, Head Office, Market Area, and Industry Position

Table 66. Bayer Broluzumab Biosimilars Models, Specifications, and Application

Table 67. Bayer Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 68. Bayer Company Profile and Main Business

Table 69. Bayer Recent Developments

Table 70. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 71. Amgen Broluzumab Biosimilars Models, Specifications, and Application

Table 72. Amgen Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 73. Amgen Company Profile and Main Business

Table 74. Amgen Recent Developments

Table 75. PlantForm Company Information, Head Office, Market Area, and Industry Position

Table 76. PlantForm Broluzumab Biosimilars Models, Specifications, and Application

Table 77. PlantForm Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 78. PlantForm Company Profile and Main Business

Table 79. PlantForm Recent Developments

Table 80. PharmaPraxis Company Information, Head Office, Market Area, and Industry Position

Table 81. PharmaPraxis Broluzumab Biosimilars Models, Specifications, and Application

Table 82. PharmaPraxis Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 83. PharmaPraxis Company Profile and Main Business

Table 84. PharmaPraxis Recent Developments

Table 85. Samsung Bioepis Company Information, Head Office, Market Area, and Industry Position

Table 86. Samsung Bioepis Broluzumab Biosimilars Models, Specifications, and Application

Table 87. Samsung Bioepis Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 88. Samsung Bioepis Company Profile and Main Business

Table 89. Samsung Bioepis Recent Developments

Table 90. Centus Company Information, Head Office, Market Area, and Industry Position

Table 91. Centus Broluzumab Biosimilars Models, Specifications, and Application

Table 92. Centus Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 93. Centus Company Profile and Main Business

Table 94. Centus Recent Developments

Table 95. Cadila Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 96. Cadila Pharmaceuticals Broluzumab Biosimilars Models, Specifications, and Application

Table 97. Cadila Pharmaceuticals Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 98. Cadila Pharmaceuticals Company Profile and Main Business

Table 99. Cadila Pharmaceuticals Recent Developments

Table 100. Dr Reddy's Company Information, Head Office, Market Area, and Industry Position

Table 101. Dr Reddy's Broluzumab Biosimilars Models, Specifications, and Application

Table 102. Dr Reddy's Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 103. Dr Reddy's Company Profile and Main Business

Table 104. Dr Reddy's Recent Developments

Table 105. Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position

Table 106. Aurobindo Pharma Broluzumab Biosimilars Models, Specifications, and Application

Table 107. Aurobindo Pharma Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 108. Aurobindo Pharma Company Profile and Main Business

Table 109. Aurobindo Pharma Recent Developments

Table 110. Biocad Company Information, Head Office, Market Area, and Industry Position

Table 111. Biocad Broluzumab Biosimilars Models, Specifications, and Application

Table 112. Biocad Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 113. Biocad Company Profile and Main Business

Table 114. Biocad Recent Developments

Table 115. MAbxience Company Information, Head Office, Market Area, and Industry Position

Table 116. MAbxience Broluzumab Biosimilars Models, Specifications, and Application

Table 117. MAbxience Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 118. MAbxience Company Profile and Main Business

Table 119. MAbxience Recent Developments

Table 120. Hetero Company Information, Head Office, Market Area, and Industry Position

Table 121. Hetero Broluzumab Biosimilars Models, Specifications, and Application

Table 122. Hetero Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 123. Hetero Company Profile and Main Business

Table 124. Hetero Recent Developments

Table 125. Biocon Company Information, Head Office, Market Area, and Industry Position

Table 126. Biocon Broluzumab Biosimilars Models, Specifications, and Application

Table 127. Biocon Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 128. Biocon Company Profile and Main Business

Table 129. Biocon Recent Developments

Table 130. Kirin Biologics Company Information, Head Office, Market Area, and Industry Position

Table 131. Kirin Biologics Broluzumab Biosimilars Models, Specifications, and Application

Table 132. Kirin Biologics Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 133. Kirin Biologics Company Profile and Main Business

Table 134. Kirin Biologics Recent Developments

Table 135. Mylan Company Information, Head Office, Market Area, and Industry Position

Table 136. Mylan Broluzumab Biosimilars Models, Specifications, and Application

Table 137. Mylan Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 138. Mylan Company Profile and Main Business

Table 139. Mylan Recent Developments

Table 140. BeiGene Company Information, Head Office, Market Area, and Industry Position

Table 141. BeiGene Broluzumab Biosimilars Models, Specifications, and Application

Table 142. BeiGene Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 143. BeiGene Company Profile and Main Business

Table 144. BeiGene Recent Developments

Table 145. Innovent Company Information, Head Office, Market Area, and Industry Position

Table 146. Innovent Broluzumab Biosimilars Models, Specifications, and Application

Table 147. Innovent Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 148. Innovent Company Profile and Main Business

Table 149. Innovent Recent Developments

Table 150. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 151. Qilu Pharmaceutical Broluzumab Biosimilars Models, Specifications, and Application

Table 152. Qilu Pharmaceutical Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 153. Qilu Pharmaceutical Company Profile and Main Business

Table 154. Qilu Pharmaceutical Recent Developments

Table 155. Hengrui Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 156. Hengrui Pharmaceuticals Broluzumab Biosimilars Models, Specifications, and Application

Table 157. Hengrui Pharmaceuticals Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 158. Hengrui Pharmaceuticals Company Profile and Main Business

Table 159. Hengrui Pharmaceuticals Recent Developments

Table 160. Hisun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 161. Hisun Pharmaceutical Broluzumab Biosimilars Models, Specifications, and Application

Table 162. Hisun Pharmaceutical Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 163. Hisun Pharmaceutical Company Profile and Main Business

Table 164. Hisun Pharmaceutical Recent Developments

Table 165. TOT BIOPHARM Company Information, Head Office, Market Area, and Industry Position

Table 166. TOT BIOPHARM Broluzumab Biosimilars Models, Specifications, and Application

Table 167. TOT BIOPHARM Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 168. TOT BIOPHARM Company Profile and Main Business

Table 169. TOT BIOPHARM Recent Developments

Table 170. Luye Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 171. Luye Pharmaceutical Broluzumab Biosimilars Models, Specifications, and Application

Table 172. Luye Pharmaceutical Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 173. Luye Pharmaceutical Company Profile and Main Business

Table 174. Luye Pharmaceutical Recent Developments

Table 175. Henlius Company Information, Head Office, Market Area, and Industry Position

Table 176. Henlius Broluzumab Biosimilars Models, Specifications, and Application

Table 177. Henlius Broluzumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 178. Henlius Company Profile and Main Business

Table 179. Henlius Recent Developments

List of Figures

Figure 1. Broluzumab Biosimilars Picture

Figure 2. Global Broluzumab Biosimilars Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Broluzumab Biosimilars Sales Quantity, (Units) & (2020-2031)

Figure 4. Global Broluzumab Biosimilars Average Selling Price (ASP), (2020-2031) & (K USD/Unit)

Figure 5. China Broluzumab Biosimilars Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Broluzumab Biosimilars Sales Quantity (Units) & (2020-2031)

Figure 7. China Broluzumab Biosimilars Average Selling Price (ASP), (K USD/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Broluzumab Biosimilars Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Broluzumab Biosimilars Market Share of Global, 2020-2031

Figure 10. Global Broluzumab Biosimilars Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Broluzumab Biosimilars Key Participants, Market Share, 2024

Figure 12. Global Broluzumab Biosimilars Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Broluzumab Biosimilars Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Broluzumab Biosimilars Production Market Share & Forecast by Region, 2020-2031

Figure 15. Broluzumab Biosimilars Industry Chain

Figure 16. Broluzumab Biosimilars Procurement Model

Figure 17. Broluzumab Biosimilars Sales Model

Figure 18. Broluzumab Biosimilars Sales Channels, Direct Sales, and Distribution

Figure 19. Beovu

Figure 20. Vsiqq

Figure 21. Others

Figure 22. by Type, Global Broluzumab Biosimilars Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Broluzumab Biosimilars Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 25. by Type, Global Broluzumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Broluzumab Biosimilars Average Selling Price (ASP), 2020-2031, (K USD/Unit)

Figure 27. ARMD

Figure 28. Kaposi Sarcoma

Figure 29. Glioblastoma

Figure 30. by Application, Global Broluzumab Biosimilars Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Broluzumab Biosimilars Revenue Market Share, 2020-2031

Figure 32. by Application, Global Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 33. by Application, Global Broluzumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Broluzumab Biosimilars Price, 2020-2031, (K USD/Unit)

Figure 35. By Region, Global Broluzumab Biosimilars Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Broluzumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 37. North America Broluzumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Broluzumab Biosimilars Consumption Value Market Share, 2024

Figure 39. Europe Broluzumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Broluzumab Biosimilars Consumption Value Market Share, 2024

Figure 41. Asia Pacific Broluzumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Broluzumab Biosimilars Consumption Value Market Share, 2024

Figure 43. South America Broluzumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Broluzumab Biosimilars Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Broluzumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 47. by Type, United States Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 50. by Type, Europe Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 53. by Type, China Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 56. by Type, Japan Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 59. by Type, South Korea Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 62. by Type, Southeast Asia Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 65. by Type, India Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Broluzumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 68. by Type, Middle East & Africa Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Broluzumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches